Bachem Holding AG Share Price
Equities
BANB
CH1176493729
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.55 CHF | -1.79% |
|
-10.80% | +14.44% |
| 12/05 | AlphaValue/Baader Europe Ups Bachem Price Target as Peptide Demand Surges | MT |
| 11/05 | Bachem: Target price revised amid strong peptide momentum |  |
| Capitalization | 513.68Cr 646.46Cr 559.83Cr 483.29Cr 900.14Cr 62TCr 914.22Cr 6.11TCr 2.38TCr 30TCr 2.43TCr 2.37TCr 1,03600Cr | P/E ratio 2026 * |
27.7x | P/E ratio 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise value | 554.17Cr 697.42Cr 603.96Cr 521.39Cr 971.09Cr 66TCr 986.28Cr 6.59TCr 2.56TCr 32TCr 2.62TCr 2.56TCr 1,11800Cr | EV / Sales 2026 * |
5.79x | EV / Sales 2027 * | 4.97x |
| Free-Float |
99.67% | Yield 2026 * |
1.47% | Yield 2027 * | 1.66% |
Last Transcript: Bachem Holding AG
| 1 day | -1.79% | ||
| 1 week | -10.80% | ||
| Current month | -10.80% | ||
| 1 month | -15.47% | ||
| 3 months | +23.29% | ||
| 6 months | +26.01% | ||
| Current year | +14.44% |
| 1 week | 66.95 |  | 77.2 |
| 1 month | 66.95 | | 83.25 |
| Current year | 53.95 | | 83.25 |
| 1 year | 48.52 | | 83.25 |
| 3 years | 43.34 | | 91.65 |
| 5 years | 43.34 | | 171 |
| 10 years | 14.09 | | 171 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 01/01/2026 | |
Alain Schaffter
DFI | Director of Finance/CFO | 49 | 01/02/2021 |
Hans Van Hees
COO | Chief Operating Officer | - | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 13/04/2011 | |
Kuno Sommer
CHM | Chairman | 70 | 25/04/2012 |
Helma Wennemers
BRD | Director/Board Member | 57 | 28/04/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/05 | Sell | -1,373 | 0.0018% | |||
| 18/03 | Buy | 248 | 0.0003% | |||
| 16/25/16 | Sell | 1,000 | 0.0013% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -10.80% | +27.06% | -26.29% | 646.46Cr | |
| -1.18% | -2.96% | -15.31% | -18.77% | 4.27TCr | |
| -4.15% | -5.24% | +263.18% | +452.70% | 3.17TCr | |
| -1.84% | +0.68% | +20.44% | -10.72% | 3.06TCr | |
| -3.51% | -6.19% | +5.57% | +19.44% | 3TCr | |
| -2.89% | -6.70% | +14.76% | +14.13% | 2.42TCr | |
| -0.18% | +3.94% | +11.24% | +4.51% | 1.32TCr | |
| -3.83% | -6.10% | - | - | 1.31TCr | |
| -0.97% | +1.60% | +53.20% | +106.80% | 1.3TCr | |
| -0.87% | -2.64% | +111.05% | +71.89% | 1.23TCr | |
| Average | -2.12% | -3.44% | +54.58% | +68.19% | 2.17TCr | |
| Weighted average by Cap. | -2.31% | -3.36% | +54.98% | +79.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 96Cr 120.54Cr 104.39Cr 90Cr 167.84Cr 11TCr 170.46Cr 1.14TCr 443.08Cr 5.55TCr 452.6Cr 442.75Cr 19TCr | 115.88Cr 145.83Cr 126.29Cr 109.03Cr 203.06Cr 14TCr 206.24Cr 1.38TCr 536.07Cr 6.72TCr 547.58Cr 535.67Cr 23TCr |
| Net income | 19Cr 23Cr 20Cr 18Cr 33Cr 2.23TCr 33Cr 221.32Cr 86Cr 1.08TCr 88Cr 86Cr 3.76TCr | 23Cr 29Cr 25Cr 21Cr 40Cr 2.72TCr 40Cr 269.62Cr 104.93Cr 1.32TCr 107.19Cr 104.86Cr 4.57TCr |
| Net Debt | 40Cr 51Cr 44Cr 38Cr 71Cr 4.86TCr 72Cr 481.27Cr 187.31Cr 2.35TCr 191.33Cr 187.17Cr 8.17TCr | 62Cr 78Cr 68Cr 59Cr 109.06Cr 7.46TCr 110.77Cr 739.76Cr 287.91Cr 3.61TCr 294.09Cr 287.69Cr 13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 68.55 CHF | -1.79% | 87,974 |
| 04/26/04 | 69.80 CHF | +2.80% | 1,35,259 |
| 03/26/03 | 67.90 CHF | -4.37% | 2,45,269 |
| 02/26/02 | 71.00 CHF | -2.14% | 1,69,474 |
| 01/26/01 | 72.55 CHF | -5.60% | 2,09,390 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BANB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition